Lymphocyte-activation gene-3, an important immune checkpoint in cancer
about
Host-Directed Therapeutic Strategies for Tuberculosis.The coexpression of multi-immune inhibitory receptors on T lymphocytes in primary non-small-cell lung cancer.Trial watch: Immune checkpoint blockers for cancer therapy.Advances in immunotherapeutic research for glioma therapy.Monoclonal Antibody Therapies for Hematological Malignancies: Not Just Lineage-Specific Targets.A safe and highly efficient tumor-targeted type I interferon immunotherapy depends on the tumor microenvironment.Prognostic value of platelet-to-lymphocyte ratio in pancreatic cancer: a comprehensive meta-analysis of 17 cohort studies.Use of the tumor-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to combination therapy with pertuzumab, trastuzumab, and docetaxel for advanced HER2-positive breast cancer.Next generation of immune checkpoint therapy in cancer: new developments and challenges.PDL1 expression is a poor-prognosis factor in soft-tissue sarcomas.Emergence of immunotherapy as a novel way to treat hepatocellular carcinoma.Immunotherapies: Exploiting the Immune System for Cancer Treatment.Tumor Necrosis Factor α and Regulatory T Cells in Oncoimmunology.Not All Immune Checkpoints Are Created EqualEmerging Therapies in the Management of Advanced-Stage Gastric CancerAdenosinergic Signaling Alters Natural Killer Cell Functional ResponsesNew strategies in immunotherapy for lung cancer: beyond PD-1/PD-L1Integrative Transcriptomic and microRNAomic Profiling Reveals Immune Mechanism for the Resilience to Soybean Meal Stress in Fish Gut and LiversLAG-3 in non-small-cell lung cancer patients' serum
P2860
Q45006012-D4F7D331-CBB7-4ADF-A4D9-7149C74789D0Q47144850-879CA950-2869-4B58-9156-25FB6D022727Q47393365-55BC04F4-C538-4F7D-AA2A-1AA3BF69FD77Q47569046-D0D50AF7-729F-4EDE-BB02-4B1FA02A8FE8Q49539698-CB0E785E-16B3-4ED2-9ECA-8B5A345CE708Q50538951-017FDE31-C7B1-4869-91E7-1AC0A2743250Q52579384-6D8328FB-340D-4F66-910E-7F811EACFEECQ52609428-C60F70B6-88B8-4574-829A-0CD7E1F8DCE7Q52653710-97917644-543C-4A74-8418-4E0DD4744DB9Q52682430-C9A69B8B-36D6-4AF4-9350-250D0EF1629AQ55008075-7F21F334-026A-4B0F-BF9C-A79D4BAAA811Q55362851-0559A402-5567-4BCC-8069-32E2313A04D2Q55386131-F267E194-E9FB-45D7-813E-327B450A33F2Q56889626-52FF48A6-EC4D-44C8-9D63-E4CFB19F9C90Q57111080-2AB8C6C8-7111-450B-A0B8-D3F568D00EAEQ58697979-B5C1F6AA-01B5-4315-A7F6-8D49BFA77724Q58740200-521B7838-338F-4AEC-BE90-E165DA3C0E01Q58754083-D40D0BCD-58A5-4147-A3F5-F73B39646EBDQ58785969-EA0C1BB1-1227-4EBC-AA53-5A45F2E47FF4
P2860
Lymphocyte-activation gene-3, an important immune checkpoint in cancer
description
2016 nî lūn-bûn
@nan
2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Lymphocyte-activation gene-3, an important immune checkpoint in cancer
@ast
Lymphocyte-activation gene-3, an important immune checkpoint in cancer
@en
Lymphocyte-activation gene-3, an important immune checkpoint in cancer
@nl
type
label
Lymphocyte-activation gene-3, an important immune checkpoint in cancer
@ast
Lymphocyte-activation gene-3, an important immune checkpoint in cancer
@en
Lymphocyte-activation gene-3, an important immune checkpoint in cancer
@nl
prefLabel
Lymphocyte-activation gene-3, an important immune checkpoint in cancer
@ast
Lymphocyte-activation gene-3, an important immune checkpoint in cancer
@en
Lymphocyte-activation gene-3, an important immune checkpoint in cancer
@nl
P2093
P2860
P3181
P356
P1433
P1476
Lymphocyte-activation gene-3, an important immune checkpoint in cancer
@en
P2093
Ashley Kowalewski
Caicun Zhou
Christopher J Rivard
Fred R Hirsch
Kim Ellison
Leslie Rozeboom
P2860
P3181
P356
10.1111/CAS.12986
P5008
P577
2016-06-14T00:00:00Z
2016-09-01T00:00:00Z